SLC26A10P
Putative solute carrier family 26 member 10P
Also known as: S2610_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for SLC26A10P in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
563 residues, UniProt reviewed canonical sequence.
>Q8NG04|SLC26A10P
1 MRLDLASLMS APKSLGSAFK SWRLDKAPSP QHTFPSTSIP GMAFALLASV PPVFGLYTSF
61 FPVLIYSLLG TGRHLSTGTF AILSLMTGSA VERLVPEPLV GNLSGIEKEQ LDAQRVGVAA
121 AVAFGSGALM LGMFVLQLGV LSTFLSEPVV KALTSGAALH VLLSQLPSLL GLSLPRQIGC
181 FSLFKTLASL LTALPRSSPA ELTISALSLA LLVPVKELNV RFRDRLPTPI PGEVVLVLLA
241 SVLCFTSSVD TRYQVQIVGL LPGGFPQPLL PNLAELPRIL ADSLPIALVS FAVSASLASI
301 HADKYSYTID SNQEFLAHGA SNLISSLFSC FPNSATLATT NLLVDAGGKT QLAGLFSCTV
361 VLSVLLWLGP FFYYLPKAVL ACINISSMRQ VFCQMQELPQ LWHISRVDFL LQVPGLCILS
421 YPTPLYFGTR GQFRCNLEWH LGLGEGEKET SKPDGPMVAV AEPVRVVVLD FSGVTFADAA
481 GAREVVQVRE RLASRCRDAR IRLLLAQCNA LVQGTLTRVG LLDRVTPDQL FVSVQDAAAY
541 ALGSLLRGSS TRSGSQEALG CGKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC26A10P can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 5
- Mean surface accessibility (rSASA)
- 0.3
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- antiporter activity
- bicarbonate transmembrane transporter activity
- chloride transmembrane transporter activity
- oxalate transmembrane transporter activity
- sulfate transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC26A10P as an antibody target. Whether an autoantibody or antibody against SLC26A10P could matter depends on whether native SLC26A10P is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC26A10P is annotated at the cell surface, where native SLC26A10P is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC26A10P as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...